«BioEq» recruits for patients with anemia caused by chronic renal disease to participate in a phase III clinical study

«BioEq» recruits for patients with anemia caused by chronic renal disease to participate in a phase III clinical study.

Study medication: Darbepoetin alfa, solution for injection

Standard medication: Darbepoetin alfa, solution for injection

We invite adult male and female patients.

You can request any additional information by phone. Please contact us at 8-812-945-22-32 to learn more.